| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/05/2009 | CA2682704A1 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 03/04/2009 | EP2031069A1 Methods for stable transduction of cells with viral vectors |
| 03/04/2009 | EP2031062A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2031056A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
| 03/04/2009 | EP2030631A1 Means and methods for treating peripheral and cardiovascular diseases via modulation of arteriogenesis |
| 03/04/2009 | EP2030020A2 Aptamers directed to recombinant muc1 |
| 03/04/2009 | EP2029756A1 Process for producing poxviruses and poxvirus compositions |
| 03/04/2009 | EP2029177A2 Method and system for preparing soft tissue for grafting, enhancing grafting results, and grafting autologous fat and adipocyte derived stem cells to soft tissue such as the breast and other tissue defects |
| 03/04/2009 | EP1904113A4 Neuroprotective effective compound |
| 03/04/2009 | EP1700120B1 Marker for neuromyelitis optica |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1115290B1 Retroviral gene delivery system and methods of use |
| 03/04/2009 | EP1088062B1 Transplants for myocardial scars |
| 03/04/2009 | EP1037918B1 Compositions to enhance the efficacy of a vaccine using chemokines |
| 03/04/2009 | CN101379192A Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 03/04/2009 | CN101379089A Anti-ILT7 antibody |
| 03/04/2009 | CN101376893A Herpes simplex virus vector, recombinant virus, host cell and pharmaceutical composition thereof |
| 03/04/2009 | CN101376892A Herpes simplex virus vector, recombinant virus, host cell and pharmaceutical composition thereof |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498316 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage |
| 03/03/2009 | US7498315 Oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers; non-toxic and effective in low doses |
| 03/03/2009 | US7498314 Expression vectors and uses thereof |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498161 Anticarcinogenic agents; gene directed enzyme prodrug therapy |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498036 Optimized expression of HPV 58 L1 in yeast |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498017 Compositions for delivering nucleic acids to cells |
| 03/03/2009 | CA2276108C Novel peptide, novel dna, and novel antibody |
| 03/03/2009 | CA2270286C Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 02/28/2009 | CA2597151A1 Hiv vaccine |
| 02/26/2009 | WO2009026576A1 Targeting rna with external guide sequences |
| 02/26/2009 | WO2009026574A2 Immunogenic compositions and uses thereof |
| 02/26/2009 | WO2009026496A1 Grp78 and tumor angiogenesis |
| 02/26/2009 | WO2009026155A2 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
| 02/26/2009 | WO2009025906A1 Novel e. coli 0157:h7 bacteriophage and uses thereof |
| 02/26/2009 | WO2009025743A2 Use of trail compositions as antiviral agents |
| 02/26/2009 | WO2009024834A2 Nucleic acids involved in viral infection |
| 02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | WO2009009591A3 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 02/26/2009 | WO2009002440A3 Compositions comprising human egfr-sirna and methods of use |
| 02/26/2009 | WO2008157459A3 Methods and systems for identifying molecular pathway elements |
| 02/26/2009 | WO2008153692A3 Microrna expression profiling of cerebrospinal fluid |
| 02/26/2009 | WO2008140621A3 Transgenic oncolytic viruses and uses thereof |
| 02/26/2009 | WO2008011071A3 Interactions of hedgehog and liver x receptor signaling pathways |
| 02/26/2009 | US20090055941 Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090054248 Connexin 40 tissue specific gene mutations |
| 02/26/2009 | US20090053808 Compositions and methods for inhibiting the expression of anti-apoptopic genes |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053222 Inhibitors of CD200 such as antibodies or antisense agents for treating cancer, tumor, leukemia |
| 02/26/2009 | US20090053185 Coagulation factor x polypeptides with modified activation properties |
| 02/26/2009 | US20090053184 Compositions comprising t cell receptors and methods of use thereof |
| 02/26/2009 | US20090053178 Use of herpes vectors for tumor therapy |
| 02/26/2009 | US20090053169 Oligonucleotide Core Carrier Compositions for Delivery of Nucleic Acid-Containing Therapeutic Agents, Methods of Making and Using the Same |
| 02/26/2009 | CA2713185A1 Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/25/2009 | EP2028278A1 RNA sequence-specific mediators of RNA interference |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2028270A2 Modified recombinant vaccina viruses and uses thereof |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027873A1 One dose vaccination with mycoplasma hyopneumoniae |
| 02/25/2009 | EP2027869A2 Neuregulin in the treatment of heart diseases |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027296A2 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 02/25/2009 | EP2026843A2 Therapeutic uses of inhibitors of rtp801l |
| 02/25/2009 | EP2026772A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 02/25/2009 | EP1753478B1 Medical device comprising a biologically active agent |
| 02/25/2009 | EP1345495B1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 02/25/2009 | EP1317289B1 Dominant negative PLB mutant for use in treating cardiac disease |
| 02/25/2009 | EP1301795B1 Method of identifying and/or isolating stem cells |
| 02/25/2009 | EP1235905B1 Device for extraction of nucleic acids |
| 02/25/2009 | CN101374853A Methods and compositions for cancer therapy using a novel adenovirus |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374502A Medicament for topical use |
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463694C Virus coat protein/receptor chimeras and methods of use |
| 02/24/2009 | US7495091 Polynucleotides encoding novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/24/2009 | US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495075 Growth differentiation factor-16 |
| 02/24/2009 | US7495068 Antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 02/24/2009 | US7494982 Modified oligonucleotides for telomerase inhibition |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494813 VAC-BAC shuttle vector system |
| 02/24/2009 | US7494806 Genetic engineering; gene therapy; packaging cells; long terminal repeats; envelope genes/proteins |
| 02/24/2009 | US7494780 Epididymis-specific defensin for evaluating and regulating male fertility |